Applied and Enviromental Microbiology 2007,73(6):1976–1983.CrossRef

MLN2238 manufacturer 25. Blanco J, Mora A, Mamani R, López C, Blanco M, Dahbi G, Herrera A, Blanco JE, Alonso MP, García-Garrote F: National survey of Escherichia coli causing extraintestinal infections reveals the spread of drug-resistant clonal groups O25b:H4-B2-ST131, O15:H1-D-ST393 and CGA-D-ST69 with high virulence gene content in Spain. J Antimicrob Chemother 2011,66(9):2011–2021.PubMedCrossRef 26. Cao X, Cavaco LM, Lv Y, Li Y, Zheng B, Wang P, Hasman H, Liu Y, FM A: Molecular characterization and antimicrobial susceptibility testing of Escherichia coli isolates from patients with urinary tract infections in 20 Chinese hospitals. J Clin Microbiol 2011,49(7):2496–2501.PubMedCrossRef 27. Ho PL, Yeung MK, Lo WU, Tse H, Li Z, Lai EL, Chow KH, To KK, WC Y: Predominance of pHK01-like incompatibility group FII plasmids encoding CTX-M-14 among extended-spectrum beta-lactamase-producing Escherichia coli in Hong Kong, 1996–2008. Diagn Microbiol Infect Dis 2012,73(2):182–186.PubMedCrossRef 28. Ortega A, Oteo J, Aranzamendi-Zaldumbide M, Bartolomé RM, Bou G, Cercenado E, Conejo MC, González-López click here JJ, Marín M, Martínez-Martínez L: Spanish multicenter study of the epidemiology and mechanisms of amoxicillin-clavulanate resistance in Escherichia coli . Antimicrob Agents Chemother 2012,56(7):3576–3581.PubMedCrossRef 29. Marcade G,

Deschamps C, Boyd A, Gautier V, Picard B, Branger C, Denamur E, Arlet G: Replicon typing of plasmids in Escherichia coli producing extended-spectrum beta-lactamases. J Antimicrob Chemother 2009,63(1):67–71.PubMedCrossRef 30.

Moreno E, Prats G, Sabate M, Perez T, Johnson JR, Andreu A: Quinolone, fluoroquinolone and trimethoprim/sulfamethoxazole resistance in relation to virulence determinants and phylogenetic background among uropathogenic Escherichia coli . J Antimicrob Chemother 2006, 57:204–211.PubMedCrossRef 31. Clermont O, Bonacorsi S, Bingen E: Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 2000,66(10):4555–4558.PubMedCrossRef P-type ATPase 32. Hilbert DW, Paulish TE, Mordechai E, Adelson ME, Gygax SE, Trama JP: Antimicrobial non-susceptibility of cervico-vaginal and rectal Escherichia coli isolates is associated with phylogeny and plasmid carriage. European Journal of Clinical Microbiology and Infections Disseases 2009,28(11):1399–1403.CrossRef 33. Vinué L, Sáenz Y, Somalo S, Escudero E, Moreno MA, Ruiz-Larrea F, Torres C: Prevalence and diversity of integrons and associated resistance genes in faecal Escherichia coli isolates of healthy humans in Spain. J Antimicrob Chemother 2008,62(5):934–937.PubMedCrossRef Competing interest Luis Martínez.-Martínez: reports that he has been a consultant for Wyeth and Pfizer, has served as speaker for Wyeth, Merck, Pfizer, and Janssen-Cilag, and has received research support from Merck, Wyeth, and Janssen-Cilag. The other authors declare that they have no competing interests.